QDZ
2022-11-05
Qualitative Cytomegalovirus Nucleic Acid-Based Detection Device For Congenital Cytomegalovirus Infection
FDA product code QDZ · 1 cleared devices
Class 2
Microbiology
- Regulation
- 21 CFR 866.3181
- Review panel
- MI
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2022-11-05 – 2022-11-05
The device is a qualitative, in vitro diagnostic test for the direct detection of Cytomegalovirus (CMV) DNA in saliva from newborn babies.
No matching devices.
Advertisement